Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Evaluation of the BacterioScan 216Dx for Standalone Preculture Screen of Preserved Urine Specimens in a Clinical Setting.

Roberts AL, Joneja U, Villatoro T, Andris E, Boyle JA, Bondi J.

Lab Med. 2017 Dec 22;49(1):35-40. doi: 10.1093/labmed/lmx052.

PMID:
29161406
2.

Randomized clinical trial comparing collagen plug and advancement flap for trans-sphincteric anal fistula.

Bondi J, Avdagic J, Karlbom U, Hallböök O, Kalman D, Šaltytė Benth J, Naimy N, Øresland T.

Br J Surg. 2017 Aug;104(9):1160-1166. doi: 10.1002/bjs.10549. Epub 2017 May 10.

PMID:
28489253
3.

A critical appraisal of transanal minimally invasive surgery (TAMIS) in the treatment of rectal adenoma: a 4-year experience with 51 cases.

Haugvik SP, Groven S, Bondi J, Vågan T, Brynhildsvoll SO, Olsen OC.

Scand J Gastroenterol. 2016 Jul;51(7):855-9. doi: 10.3109/00365521.2016.1157891. Epub 2016 Mar 22.

PMID:
27000415
4.

Adaptation of trustworthy guidelines developed using the GRADE methodology: a novel five-step process.

Kristiansen A, Brandt L, Agoritsas T, Akl EA, Berge E, Bondi J, Dahm AE, Granan LP, Halvorsen S, Holme PA, Flem Jacobsen A, Jacobsen EM, Neumann I, Sandset PM, Sætre T, Tveit A, Vartdal T, Guyatt G, Vandvik PO.

Chest. 2014 Sep;146(3):727-734. doi: 10.1378/chest.13-2828.

PMID:
25180723
5.

[Antithrombotic therapy in surgery].

Vandvik PO, Granan LP, Holme PA, Bondi J.

Tidsskr Nor Laegeforen. 2014 May 13;134(9):925. doi: 10.4045/tidsskr.13.1580. eCollection 2014 May 13. Norwegian. No abstract available.

6.

A total-synthesis framework for the construction of high-order colloidal hybrid nanoparticles.

Buck MR, Bondi JF, Schaak RE.

Nat Chem. 2011 Nov 13;4(1):37-44. doi: 10.1038/nchem.1195.

PMID:
22169870
7.

Purification and magnetic interrogation of hybrid Au-Fe3O4 and FePt-Fe3O4 nanoparticles.

Beveridge JS, Buck MR, Bondi JF, Misra R, Schiffer P, Schaak RE, Williams ME.

Angew Chem Int Ed Engl. 2011 Oct 10;50(42):9875-9. doi: 10.1002/anie.201104829. Epub 2011 Sep 6.

PMID:
21898742
8.

Pawley and Rietveld refinements using electron diffraction from L1₂-type intermetallic Au₃Fe₁-x nanocrystals during their in-situ order-disorder transition.

Luo Z, Vasquez Y, Bondi JF, Schaak RE.

Ultramicroscopy. 2011 Jul;111(8):1295-304. doi: 10.1016/j.ultramic.2011.04.003. Epub 2011 Apr 22.

PMID:
21864770
9.

The Prognostic Impact of Protein Expression of E-Cadherin-Catenin Complexes Differs between Rectal and Colon Carcinoma.

Aamodt R, Bondi J, Andersen SN, Bakka A, Bukholm G, Bukholm IR.

Gastroenterol Res Pract. 2010;2010. pii: 616023. doi: 10.1155/2010/616023. Epub 2010 Aug 16.

10.

Differences in protein expression and gene amplification of cyclins between colon and rectal adenocarcinomas.

Aamodt R, Jonsdottir K, Andersen SN, Bondi J, Bukholm G, Bukholm IR.

Gastroenterol Res Pract. 2009;2009:285830. doi: 10.1155/2009/285830. Epub 2009 Dec 15.

11.

Large-scale genomic instability in colon adenocarcinomas and correlation with patient outcome.

Bondi J, Pretorius M, Bukholm I, Danielsen H.

APMIS. 2009 Oct;117(10):730-6. doi: 10.1111/j.1600-0463.2009.02527.x.

PMID:
19775341
12.

Chemical synthesis of air-stable manganese nanoparticles.

Bondi JF, Oyler KD, Ke X, Schiffer P, Schaak RE.

J Am Chem Soc. 2009 Jul 8;131(26):9144-5. doi: 10.1021/ja901372q.

PMID:
19566087
13.

An increase in the number of adhesion proteins with altered expression is associated with an increased risk of cancer death for colon carcinoma patients.

Bondi J, Bukholm G, Nesland JM, Bakka A, Bukholm IR.

Int J Colorectal Dis. 2006 Apr;21(3):231-7. Epub 2005 Jun 4.

PMID:
15937692
14.
15.
16.

Presence of isolated tumour cells in mesenteric lymph nodes predicts poor prognosis in patients with stage II colon cancer.

Bukholm IR, Bondi J, Wiik P, Nesland JM, Andersen SN, Bakka A, Bukholm G.

Eur J Surg Oncol. 2003 Dec;29(10):862-6.

PMID:
14624779
17.

Intraoperative manometry to assess the esophagogastric junction during laparoscopic fundoplication and myotomy.

Nussbaum MS, Jones MP, Pritts TA, Fischer DR, Wabnitz B, Bondi J.

Surg Laparosc Endosc Percutan Tech. 2001 Oct;11(5):294-300.

PMID:
11668225
18.

Low-dose intravenous erythromycin: effects on postprandial and fasting motility of the small bowel.

Medhus AW, Bondi J, Gaustad P, Husebye E.

Aliment Pharmacol Ther. 2000 Feb;14(2):233-40.

19.

Mycobacterial growth and bacterial contamination in the mycobacteria growth indicator tube and BACTEC 460 culture systems.

Cornfield DB, Beavis KG, Greene JA, Bojak M, Bondi J.

J Clin Microbiol. 1997 Aug;35(8):2068-71.

20.

Acidic fibroblast growth factor: evaluation of topical formulations in a diabetic mouse wound healing model.

Matuszewska B, Keogan M, Fisher DM, Soper KA, Hoe CM, Huber AC, Bondi JV.

Pharm Res. 1994 Jan;11(1):65-71.

PMID:
7511240
21.
22.

Formulation design of acidic fibroblast growth factor.

Tsai PK, Volkin DB, Dabora JM, Thompson KC, Bruner MW, Gress JO, Matuszewska B, Keogan M, Bondi JV, Middaugh CR.

Pharm Res. 1993 May;10(5):649-59.

PMID:
7686672
23.

A new approach for three-dimensional reconstruction of arterial ultrasonography.

Franceschi D, Bondi JA, Rubin JR.

J Vasc Surg. 1992 May;15(5):800-4; discussion 804-5.

PMID:
1578535
24.

Estradiol distribution and penetration in rat skin after topical application, studied by high resolution autoradiography.

Bidmon HJ, Pitts JD, Solomon HF, Bondi JV, Stumpf WE.

Histochemistry. 1990;95(1):43-54.

PMID:
2286532
25.

Antiparkinsonian efficacy of a novel transdermal delivery system for (+)-PHNO in MPTP-treated squirrel monkeys.

Rupniak NM, Tye SJ, Jennings CA, Loper AE, Bondi JV, Hichens M, Hand E, Iversen SD, Stahl SM.

Neurology. 1989 Mar;39(3):329-35.

PMID:
2784549
26.

Therapeutic efficacy of a novel transdermal delivery system for (+)-PHNO in parkinsonian squirrel monkeys.

Rupniak NM, Tye SJ, Jennings CA, Loper AE, Bondi JV, Hichens M, Iversen SD, Stahl SM.

J Neurol Neurosurg Psychiatry. 1989 Feb;52(2):289-90. No abstract available.

27.

The antiparkinsonian actions and pharmacokinetics of transdermal (+)-4-propyl-9-hydroxynaphthoxazine (+PHNO): preliminary results.

Coleman RJ, Lange KW, Quinn NP, Loper AE, Bondi JV, Hichens M, Stahl SM, Marsden CD.

Mov Disord. 1989;4(2):129-38.

PMID:
2733705
28.
29.

2'-Nor-2'-deoxyguanosine is an effective therapeutic agent for treatment of experimental herpes keratitis.

Davies ME, Bondi JV, Grabowski L, Schofield TL, Field AK.

Antiviral Res. 1987 Feb;7(2):119-25.

PMID:
3495237
30.

Dissolution rate studies of compression-molded units made from hydroxypropyl cellulose films.

Grabowski LA, Bondi JV, Harwood RJ.

J Pharm Sci. 1985 May;74(5):540-4.

PMID:
4020630
31.

Initial evaluation of transdermal timolol: serum concentrations and beta-blockade.

Vlasses PH, Ribeiro LG, Rotmensch HH, Bondi JV, Loper AE, Hichens M, Dunlay MC, Ferguson RK.

J Cardiovasc Pharmacol. 1985 Mar-Apr;7(2):245-50.

PMID:
2581075
32.
33.
34.

Cholesterol metabolism in patients with resection of ileum and proximal colon.

Ho KJ, Bondi JL.

Am J Clin Nutr. 1977 Feb;30(2):151-9.

PMID:
835501
35.

Bioavailability assessment under quasi- and nonsteady-state conditions III: Application.

Bondi JV, Hucker HB, Yeh KC, Kwan KC.

J Pharm Sci. 1976 Nov;65(11):1657-65.

PMID:
1036500
36.
37.

Experimental gouty synovitis caused by bacterial endotoxin adsorbed onto urate crystals.

Van Arman CG, Carlson RP, Kling PJ, Allen DJ, Bondi JV.

Arthritis Rheum. 1974 Jul-Aug;17(4):439-49. No abstract available.

PMID:
4604461
38.

Effect of adsorbed surfactant on particle--particle interactions in hydrophobic suspensions.

Bondi JV, Schnaare RL, Niebergall PJ, Sugita ET.

J Pharm Sci. 1973 Oct;62(10):1731-3. No abstract available.

PMID:
4752127
39.

"Vigorous" achalasia. Its clinical interpretation and significance.

Bondi JL, Godwin DH, Garrett JM.

Am J Gastroenterol. 1972 Aug;58(2):145-55. No abstract available.

PMID:
5056512
40.

[Effect of prednisone on the intestinal mucosa in celiac disease].

De Larrechea I, Ibarra R, Posse JC, Bondi JL.

Medicina (B Aires). 1970 Sep-Oct;30(5):479-84. Spanish. No abstract available.

PMID:
5510022
41.

[Protein-losing enteropathy. Intestinal lymphagiectasis].

De Larrechea I, Ibarra R, Bondi JL, Posse JC.

Prensa Med Argent. 1970 Jul 3;57(18):869-74. Spanish. No abstract available.

PMID:
5457718
42.

[Changes in the mucosa of the small intestine in intestinal lymphoma].

Ibarra R, Bondi JL, Posse JC, De Larrechea I.

Medicina (B Aires). 1970 May-Jun;30(3):234-40. Spanish. No abstract available.

PMID:
5520760
43.

[Alterations in the small intestine mucosa in intestinal lymphoma].

Ibarra R, Bondi JL, Posse JC, De Larrechea I.

Rev Esp Enferm Apar Dig. 1970 Apr 15;31(2):177-88. Spanish. No abstract available.

PMID:
5525216
44.

[Selective changes in the absorption of carbohydrates].

De Larrechea I, Bondi JL, Posse JC.

Medicina (B Aires). 1969 Jul-Aug;29(4):285-92. Spanish. No abstract available.

PMID:
5382842
45.

[Changes in the metabolism of absorbent cells in the primary malabsorption syndrome].

Ibarra R, Bondi JL, Posse JC, De Larrechea I.

Prensa Med Argent. 1967 Apr 21;54(8):345-50. Spanish. No abstract available.

PMID:
5614089
46.

[Relation between ATPase and lipid absorption in the normal and pathological intestine].

Ibarra R, Posse JC, Bondi JL, De Larrechea I.

Medicina (B Aires). 1967 Mar-Apr;27(2):75-8. Spanish. No abstract available.

PMID:
4234493
47.

[Zollinger-Ellison Syndrome].

Bondi JL.

Rev Sanid Milit Argent. 1966 Jan-Dec;65(1):45-53. Spanish. No abstract available.

PMID:
5986732
48.

[Jejunal complications caused by peroral biopsy. A case of intestinal pseudoperforation].

Bondi JL, De Larrechea I.

Prensa Med Argent. 1965 Dec 31;52(49):3037-8. Spanish. No abstract available.

PMID:
5888460

Supplemental Content

Support Center